Medindia
Medindia LOGIN REGISTER
Advertisement

ECRI Institute Examines Challenging Landscape of Genetic Testing: Web Conference December 10 Offers Guidance for Providers and Health Plans

Saturday, December 5, 2009 General News
Advertisement
PLYMOUTH MEETING, Pa., Dec. 4 Continuous advances in genetic research and molecular technologies, driven by the completion of the Human Genome Project more than a decade ago, have catapulted molecular diagnostic testing into one of the fastest growing and most costly service areas. The number of tests available exceeds 3,000 and counting. ECRI Institute(R) (www.ecri.org), an independent nonprofit that researches the best approaches to improving patient care, is offering a Web conference on Thursday, December 10, to help healthcare payers and providers understand the complex genetic testing market.
Advertisement

Genetic Testing Uncovered: What Providers and Payers Need to Know, a 90-minute educational webinar led by ECRI Institute's Evidence-based Practice Center staff, is being held Thursday, December 10, 2009, from 1:00 to 2:30 p.m. ET. The program is approved for 1 AMA PRA Category 1 Credit (TM).
Advertisement

The experts will present an overview of the genetic testing market and will examine key issues that payers and providers are struggling to answer, such as:

ECRI Institute speakers include Vivian H. Coates, VP, Information Services and Health Technology Assessment; Karen M. Schoelles, M.D., SM, FACP, Director, ECRI Institute Evidence-based Practice Center, Medical Director, Health Technology Assessment Group; and Fang Sun, M.D., Senior Research Analyst, Technology Assessment. A live interactive question and answer session will provide an opportunity for participants to pose questions to the experts.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). ECRI Institute is accredited by the ACCME to provide continuing medical education for physicians. ECRI institute designates this entire education activity for a maximum of 1 AMA PRA Category 1 credits (TM). Physicians should claim credit commensurate with the extent of their participation in this activity.

Web conference registration is free for members of ECRI Institute's Health Technology Assessment Information Service (HTAIS members should contact [email protected] for coupon code); $249 for nonmembers; and $149 for government agencies (use coupon code GGENE09). The deadline for registration is close of business on Tuesday, December 8, 2009.

For information about the Web conference, Genetic Testing Uncovered: What Providers and Payers Need to Know, or to register, please visit https://www.ecri.org/Conferences/AudioConferences/Pages/Genetic_Testing.aspx or contact ECRI Institute at [email protected]; by phone at (610) 825-6000, ext. 5891, or by fax at (610) 834-1275.

ECRI Institute (www.ecri.org), a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes are best to enable improved patient care. As pioneers in this science for 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. Strict conflict-of-interest guidelines ensure objectivity. ECRI Institute is designated a Collaborating Center of the World Health Organization and an Evidence-based Practice by the U.S. Agency for Healthcare Research and Quality. ECRI Institute PSO, listed as a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services, strives to achieve the highest levels of safety and quality in healthcare by collecting and analyzing patient safety information and sharing lessons learned and best practices.

-- What are genetic tests and how are they used in different patient populations? -- How are the tests regulated and by whom? -- What quality issues can affect test performance and who can perform them? -- How should tests be evaluated to assess their analytic validity, clinical accuracy, and clinical utility? -- What are the unresolved controversies about test development, regulation, coding, and clinical use? -- What should health plans consider when trying to evaluate evidence on tests?

SOURCE ECRI Institute
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close